TABLE 4.
Patient‐Based Interobserver Agreement for Evaluating the Representative Radiological Findings of COVID‐19 With CT and UTE‐MRI
Indexes | Methods | ICC | 95% CI | P |
---|---|---|---|---|
No. of affected lobes | CT | 1.000 | 1.000–1.000 | <0.05 |
UTE‐MRI | 1.000 | 1.000–1.000 | <0.05 | |
No. of GGO | CT | 0.982 | 0.964–0.992 | <0.05 |
UTE‐MRI | 0.968 | 0.935–0.985 | <0.05 | |
No. of consolidation | CT | 0.990 | 0.980–0.995 | <0.05 |
UTE‐MRI | 0.989 | 0.978–0.995 | <0.05 | |
No. of GGO with consolidation | CT | 0.998 | 0.997–0.999 | <0.05 |
UTE‐MRI | 0.997 | 0.994–0.999 | <0.05 | |
No. crazy paving pattern | CT | 1.000 | 1.000–1.000 | <0.05 |
UTE‐MRI | 0.958 | 0.958–0.981 | <0.05 | |
No. of linear opacities | CT | 0.961 | 0.922–0.982 | <0.05 |
UTE‐MRI | 0.939 | 0.839–0.972 | <0.05 | |
Total severity score | CT | 0.993 | 0.985–0.997 | <0.05 |
UTE‐MRI | 0.994 | 0.989–0.997 | <0.05 |